Demonstration of clinically silent plaque rupture by dual-source computed tomography.

antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the cardiac arrest study hamburg (CASH). Circulation 2000;102:748–754. 9. Daubert JP, Sesselberg HW, Huang DT. Implantable cardioverterdefibrillators for primary prevention: how do the data pertain to the aged? Am J Geriatr Cardiol 2006;15:88–92. 10. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H Kutalek SP, Sharma A; Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288: 3115–3123. 11. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, CullerSD, Simon AW. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverterdefibrillators. J Am Coll Cardiol 2006;47:2493–2497.